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Abstract
Introduction: Diabetes is the leading cause of end-stage renal disease (ESRD) in the United States (US), with 37 million
having chronic kidney disease. Despite national guidelines recommendations for diabetic nephropathy screening with
urine albumin-to-creatinine ratio (UACR), less than 50% receive full screening.
Our Internal Medicine residents led a quality improvement project to increase diabetic nephropathy screening rate
with UACR in our resident clinic by 50% in one academic year.
Methods: We conducted the resident-led quality improvement project from July 2021 to April 2022. We reviewed the
electronic medical records (EMR) from our clinic pre-intervention July 2020 to June 2021 and compared this to post
intervention July 2021 to March 2022 determining the nephropathy screening rates in patients with diabetes. Our interventions included resident education, pre and post surveys to test foundational knowledge, adding UACR in the
affordable laboratory order form and establishing normal reference range of UACR in the EMR.
Results: We collected 217 patients with diabetes, 27% were uninsured, 38% had Medicare/Medicaid and 90% identiﬁed
as Hispanic. Comparing pre to post intervention, there was a signiﬁcant change of 45 (20.7%) vs 71 (32.7%) patients
screened for diabetic nephropathy with a UACR. The correct average score of knowledge-based questions was 82% on
the pre survey, which increased to 88% in the post survey.
Conclusion: Our study showed promising results on improving diabetic nephropathy screening. The comprehensive
approach including resident education about diabetic nephropathy screening with UACR and more so facilitating the
order set in the EMR were key to achieve this goal.
Keywords: Diabetic nephropathy screening, Hispanic population, Resident education, Quality improvement

1. Introduction

D

iabetic nephropathy is the leading cause of
end stage renal disease (ESRD) in the United
States (US) and 37 million Americans suffer from
chronic kidney disease.1,2 Despite this high prevalence and guidelines for screening for diabetic nephropathy, a 2021 study examining over 1.8 million
patients with diabetes found that less than 50%
received full screening with the recommended
annual urine albumin-to-creatinine ratio (UACR)

and the estimated glomerular ﬁltration rate
(eGFR).3,4
The American Diabetic Association (ADA) recommends an assessment of glomerular function and
of urine albumin excretion annually in patients with
diabetes.5 Similarly, the US Kidney Disease Outcomes Quality Initiative (KDOQI) and Kidney Disease Improving Global Outcomes (KDIGO)
recommend the UACR and the eGFR for annual
screening for diabetic nephropathy.3 The spot
collection of the UACR is endorsed over the 24-h
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urine collection to improve compliance and
feasibility.6e9 Nevertheless, multiple studies across
different laboratories and practice settings demonstrate
suboptimal
diabetic
nephropathy
screening.2e4
Barriers to albuminuria testing include inefﬁcient
collection of urine sample, confusion of UACR with
microalbumin, exclusion of UACR from order sets,
lack of provider knowledge in ordering and interpreting, laboratory errors in reporting, and lack of a
standardized way to measure urine albumin.3 To
address these barriers, quality improvement efforts
have succeeded with electronic clinical decision
support systems, educational sessions, guideline
reminders and processes to collect labs immediately
following the clinic visit.3,9,10 A 2020 article from
Curran et al. described senior residents leading a
successful quality improvement project to improve
the resident clinic compliance with the Medicare
Healthcare Effectiveness Data and Information Set
(HEDIS) measure for “medical attention to nephropathy.”11 Other studies have been done in
resident clinics but the effect and feasibility of a
resident-led quality improvement initiative for diabetic nephropathy is not well-known.11e13
Our resident-led quality improvement initiative
also aims to address health disparities as we are
located in Hidalgo County in South Texas with a
30.7% prevalence of diabetes compared to 12.3%
nationally; with most of the patients with poor
health literacy, and inadequate access to medical
care.14 Obesity prevalence for Hidalgo county is
42.9% well above the state prevalence of 35.7% and
also above the national average of 41.9%.15,16 The
region is 92.5% Hispanic, with 31.2% below the
poverty line and 29.7% uninsured.17 Our University
of Texas Rio Grande Valley (UTRGV) - Doctors
Hospital at Renaissance (DHR) Internal Medicine
resident clinic patient population averages 27%
uninsured and 38% Medicare/Medicaid. Though
some teams have found success in improving diabetic nephropathy screening in the underinsured,
the impact of a quality improvement initiative in
this high-risk population is not well-established.10,18
However, there have been successful attempts at
increasing other healthcare screening such as rate of
colon cancer or cervical cancer in the Hispanic
population.19,20
In order to improve healthcare disparities for these
underserved populations and following evidencebased guideline recommendations, we led a quality
improvement initiative to increase diabetic nephropathy screening rate with UACR in our UTRGVDHR Internal Medicine resident clinic by 50% from
baseline screening rate in one academic year.

2. Methods
2.1. Context
In the internal medicine residency at UTRGVDHR all residents must lead a group QI project each
academic year. Our group of 11 residents and 2
faculty led this project from July 2021 to April 2022
in our resident clinic where all 50 residents have a
continuity clinic. Following the Institute for
Healthcare Improvement model, we began by
developing a driver diagram to identify primary and
secondary drivers to develop ideas to reach our aim
(Fig. 1).
For our EMR review our inclusion criteria were
patients with diabetes as determined by diabetesrelated diagnoses in the EMR. Pre-intervention
dates were visits between 7/1/2020 to 6/30/2021. We
kept the list of patients from that academic year and
used the same set of patients for the intervention
academic year to assess compliance with nephropathy screening. Post-intervention dates were 7/1/
2021 to 3/30/22. The identical list of patients was
used to extract data in the pre and post intervention
periods. Exclusion criteria were new patients ﬁrst
seen after 7/1/2021, patients not seen since 7/1/2020,
patients with ESRD, patients without diabetes
(determined through chart review, patient was seen
with no documentation of diabetes diagnosis, no
supporting labs to conﬁrm the diagnosis), and patients whose primary care physician was not a
resident. The study was deemed exempt from IRB
by UTRGV IRB.
To determine compliance with nephropathy
screening, we used a population health management tool called the Dynamic Worklist feature in the
Cerner EMR to search for patients whose primary
physician was one of our residents, patients who
had diabetes and patients who had been seen in the
DHR Internal Medicine GME clinic after 07/01/2020.
We checked the charts of 272 patients who met the
inclusion criteria to see if they had a completed
UACR from 7/1/2020e6/30/2021. We excluded 55
patients. A total of 217 patients remained, of which
90% were of Hispanic ethnicity, who were included
in this study (Fig. 2). There was 1 patient with type 1
diabetes, who was included in the 217 patients. For
the patients who did not have UACR screening in
the pre-intervention period, we checked to see if
they had different methods of screening, including
urine microalbumin level, urine protein-creatinine
ratio, urinalysis, or no urine studies. We compared
the number of pre-intervention (from 7/1/2020e6/
30/2021) and post-intervention (from 7/1/2021e3/31/
2022) compliance with UACR screening and plotted
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Fig. 1. Driver diagram highlighting the primary and secondary drivers that affect our goal.

the number of UACR results each month during the
pre and post intervention periods by all 50 residents
in the clinic as a surrogate marker.

feasible next step and therefore we made this the
top priority in our project for the lab.
2.3. Electronic medical record UACR optimization

2.2. Affordable lab order form
With 27% of our patients uninsured and 38%
Medicare/Medicaid in our clinic, many residents
use an affordable lab order form (see Appendix
Image 1), a physical paper form with the total out of
pocket cost of individual and package labs at our inhospital laboratory. The current form listed urine
microalbumin alone with no option for urine
creatinine or any ratio. We aimed to have the UACR
added to the affordable lab order form to aid physicians and patients in obtaining proper nephropathy screening (see Appendix Image 2).
With our faculty support and enlisting the support
of the Chief Academic Ofﬁcer at our clinical site
DHR, we initiated monthly meetings to propose
these changes to the laboratory and laboratory order
form. In discussion with our laboratory partners,
updating the affordable lab order form was a

The EMR at our local institution did not have a
reference range for UACR and therefore abnormal
results were not ﬂagged. Physicians are accustomed
to having abnormal results automatically highlighted and are frequently reviewing 20 or more
individual results. The current system depends on
physicians to analyze the UACR, know the normal
values or search for reference ranges. In the same
meetings mentioned above with our faculty, Chief
Academic Ofﬁcer and laboratory leadership, we
proposed implementing a reference range for the
UACR into the system-wide EMR. We conducted
several meetings to discuss the importance of these
changes, follow the appropriate protocols for
implementing changes in laboratory results, and
provided examples from other laboratories reporting abnormal UACR values. The laboratory partners
identiﬁed this requested change as more complex
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Fig. 2. Pre-intervention analysis of patients with diabetes in resident internal medicine clinic.

and therefore we listed it as the second priority,
after getting the affordable lab order form updated.
2.4. Statistical analysis
Resident Education. To test the foundational
knowledge of the residents on diabetic nephropathy
screening, we created a pre-survey in RedCap to
distribute prior to our didactic session. The survey
consisted of 7 questions with 6 knowledge-based
questions and 1 question to assess resident's perception of barriers to diabetic nephropathy screening.
We then conducted a didactic session on the
importance of screening for diabetic nephropathy,
the method for screening, frequency, and timing for
screening, and how to interpret normal and
abnormal values. We constructed a “diabetic patient
order set” on the EMR and showed the residents
how to access this order set. This order set included
ordering glucometer, glucose strips, lancets,
HgbA1c, CMP, lipid panel, UACR, annual foot exam,
and referrals to ophthalmology and optometry.
Independent Probabilities. We then administered
an anonymous post-survey to the residents during
noon conference and resident leaders of the project
encouraged their colleagues to complete surveys.
We used independent analysis to compare pre and

post-survey results. Due to the resident survey
being anonymous, we were unable to perform
pairing during our analysis, leading to a loss of
statistical power.
Conditional Probabilities. In this cohort study,
data from 217 patients with diabetes was collected.
Success was considered if a patient was screened
obtaining dichotomized variables (0 ¼ No, 1 ¼ Yes).
Paired analysis for patients was done in a two by two
contingency table. We categorized the visits as initial
and post intervention in order to calculate the conditional probability of successfully ordering a test in
the second visit. We monitored the improvement of
ordering the test in the second visit conditioned if
the test was obtained or not in the ﬁrst visit. . The
same patient list was used in the pre intervention
and post intervention data collection. The effect of
the intervention was calculated with risk ratio, and
absolute difference in the pre and post intervention
period. The 95% conﬁdence intervals were calculated with Wolff method and chi squared with
McNemar for paired samples in patients. All calculations were made with Stata release 17.0.

3. Results
In the pre-intervention data collection, out of the
217 total patients, 172 (79.5%) patients did not have a

UACR. From the patients without UACR, 40 (23.3%)
patients had a urine microalbumin level only, 57
(33.1%) patients had a urine protein/creatinine ratio,
63 (36.6%) patients had a urinalysis (UA), 48 (27.9%)
patients had no urine studies (Fig. 2). 36 patients had
two studies either a UA plus a microalbumin or a
UA plus a protein/creatinine ratio. From the 217
patients included, 195 (89.9%) were inappropriately
screened with a GFR through a general basic
metabolic panel.
Regarding the affordable lab order form (see
Appendix Image 1 and Image 2), the laboratory
director was able to obtain a UACR for $30 out of
pocket, compared to the urine microalbumin
order alone which was $10. The updated order on
the paper also required an updated order in the
EMR and both were accomplished in March 2022
(Fig. 3).

5

Regarding the EMR UACR optimization, the laboratory had various steps that required time and
deliberation including checks from their accrediting
agency, The College of American Pathologist,
including information going from the test environment to the production environment for validation.
During meetings the resident leaders and program
faculty used patient safety, the Clinical Learning
Environment Review program and other shared
goals between the residency and the clinical site to
make progress on the goals. The reference range
and highlighted abnormal values went “live” March
2022 (Fig. 3).
Regarding resident knowledge, 47 of 50 (94%) of
residents completed the pre-survey and 50 out of 50
(100%) residents completed the post-survey. The
pre-intervention survey showed the correct average
score of knowledge-based questions was 82%. The

Fig. 3. Examples in pre and post intervention improvements including ﬂagged abnormal lab values and the interpretation of lab values.
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resident-perceived most frequent reason why the
UACR was not completed was “patient lost to follow
up”. The post-intervention survey showed an increase in the average score to 88%. The residentperceived most frequent reason why the UACR was
not completed was a tie between “provider not
aware to screen for diabetic nephropathy” and
“patient lost to follow up”, as seen in Fig. 4. The
average of correct answers per question is noted in
Table 1.
Pre and post surveys were analyzed using independent analysis due to surveys being anonymous
and unable to pair among residents. This led to a
decrease in statistical power resulting in a positive
trend in knowledge base, however without statistical signiﬁcance. This was aggravated by our low
sample size.

In the post-intervention data collection, the
probability ratio for being screened before intervention (Period 1) was 1.6 (95% CI 1.2, 2.1;
p ¼ 0.003). If screening was only completed in the
post-intervention period (Period 2) the probability
ratio increased to 3.2 (95% CI 2.4, 4.3; p < 0.001) with
an attributable increase on probability ratio due to
the intervention of 46%, (95% CI 37, 56%), as seen in
Fig. 5.
The number of UACRs performed per month in
our clinic is plotted over time along with notations
of our interventions in Fig. 6.

4. Discussion
The goal of this project was to increase diabetic
nephropathy screening rate in our GME clinic by
50% from our baseline. This was achieved by

Fig. 4. Comparison of pre and post intervention survey data on what is the resident-perceived most common cause why patients are not screened for
diabetic nephropathy showing no signiﬁcant difference (chi-square ¼ 2.93, d.f. ¼ 8, p-value ¼ 0.57).
Table 1. Comparison of the number of residents who answered correctly on knowledge-based questions on pre and post intervention surveys. Post
intervention survey showed an improving trend in our knowledge base.
Question

Pre-Intervention # of
residents who answered
correctly (%)

Post-Intervention # of
residents who answered
correctly (%)

p-values

What is the purpose of screening for diabetic nephropathy?
When do you start screening for diabetic nephropathy?
What is the recommended screening strategy
for diabetic nephropathy?
What is a positive UACR test?
How often do we screen diabetic patients for nephropathy?
What is the recommended treatment for diabetic nephropathy?

46/47 (97.9%)
28/47 (59.6%)
40/47 (85.1%)

50/50 (100%)
34/50 (68%)
43/50 (86%)

0.27
0.38
0.90

40/47 (85.1%)
43/47 (91.5%)
33/47 (70.2%)

47/50 (94%)
49/50 (98%)
40/50 (80%)

0.14
0.14
0.26
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Fig. 5. Comparison of number of UACR performed pre and post intervention. Pre-Intervention: 45 UACRs performed (20.7%). Post-Intervention: 71
UACRs performed (29%). * RR ¼ 3.2 (95% CI 2.4, 4.3; p-value <0.001), if no screening in Pre-Intervention and screened in Post-Intervention.

Fig. 6. Number of UACR performed over the study period. Dotted line separates the “Pre-Intervention” Period on left and “Post-Intervention” on
right. Aim statement was developed in August 2021. Didactic session was held in October 2021. UACR order was added to the institution-wide EMR
in March 2022.
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increasing UACR screenings from 20.7% to 32.7%.
The primary drivers we identiﬁed as contributing to
our goal were 1) lack of physician experience, 2) the
electronic medical record system, 3) compliance,
and 4) cost. These primary drivers had speciﬁc
secondary drivers that were identiﬁed and listed
(Fig. 1). Speciﬁcally, Clinic No-Shows are the main
secondary driver under compliance. This was
addressed with patient education on the importance
of obtaining a timely UACR result. In the last column on the right are listed speciﬁc interventions we
have implemented to address each primary and
secondary driver.
The resident-led nature of this project led to an
increase resident buy-in to complete surveys and
actively participate. Leaders of this QI project used
several interventions including resident education,
changes in affordable lab orders to include UACR
and changes in EMR results. EMR use inﬂuences
physician decisions. Being alerted to abnormal lab
values prompts a physician to act on them. Therefore, the most enduring interventions of this QI
project include changes to the EMR, addition of
UACR reference ranges, ﬂagging of abnormal results and addition of UACR in the affordable lab
order form which ultimately occurred towards the
end of the post-intervention. This cohort study
shows that a resident-led quality improvement
initiative with faculty support was successful in
signiﬁcantly improving screening for diabetic nephropathy in a Hispanic-predominant clinic
population.
Our study in the context of other works. Our study
contributes to the literature supporting the effectiveness of quality improvement projects in resident
clinics to improve diabetic nephropathy.11e13
Furthermore, it adds to the small amount of literature available showing the success of resident-led
quality improvement projects to address this national gap in screening for diabetic nephropathy
such as Curran's resident-led project using the
HEDIS measure for nephropathy.11 The beneﬁts of a
resident-led approach include accomplishing the
Accreditation Council for Graduate Medical Education requirements surrounding experiential
learning in quality improvement, accomplishing the
Clinical Learning Environment Review requirements, and resident “buy in” or engagement.21
Residents were proud to have made a long-term
impact on our community as recognizing the presence of diabetic nephropathy is the ﬁrst step in
treating and halting progression of this disease that
is so prevalent in our region.
Reﬂections on implications of our results. Our preintervention diabetic nephropathy screening rates at

1 in 5 patients successfully screened are similar to
national rates suggesting that our population and/or
providers face similar barriers to others.3,22 It is
interesting to note that 85% of residents answered
the questions about nephropathy screening and
UACR correctly in the pre-survey, yet, our clinic
population was only 20.7% correctly screened in the
pre-intervention period. Though we did not chart
review to identify speciﬁc barriers such as patient
noncompliance or competing priorities during ofﬁce
visits, high pre-survey medical knowledge leads us
to believe that lack of medical knowledge was not a
major contributing factor to low pre-intervention
nephropathy screening rates in our resident clinic.
Our resident-perceived barriers are consistent
with multiple studies showing high testing rates
with eGFR and poor adherence for testing with
UACR.3,22 This factor is likely secondary to eGFR
and serum creatinine being part of BMPs and CMPs
which are routinely ordered for multiple reasons.
The two tests are also blood tests which often come
with less logistical difﬁculties than urine collection.
Our study serves as groundwork to educate the
health care community from moving away from
misappropriately using eGFR for diabetic nephropathy screening and adequately using UACR
as established in the national guidelines.
The success of our intervention, similar to other
successful QI projects for diabetic nephropathy,
depended partially on EMR optimization.3,9,10
Unique to our study was the approach to address
our underinsured population by updating our
affordable lab order form. For years, residents had
used this lab order form which obtained a urine
microalbumin level alone which could not be clinically interpreted, and residents had no way of
knowing the cost if they were to order separately a
UACR. This study served as a benchmark in
assessing general resident knowledge. Through its
completion, this study also highlighted that motivated residents should be key stakeholders in
institutional quality improvement efforts as they can
have inﬂuence over a health system to implement
system wide changes.
Limitations of our study. We faced several challenges including a cumbersome EMR where the
health maintenance tab did not effectively record
core measures for patients with diabetes, outside
labs being scanned in a separate folder, and an
extended amount of time to go through the processes to change our lab reporting and ordering.
With our third-year residents being the leaders of
this resident-led project, we concluded data collection by March to allow for project completion prior
to graduation. This resulted in the data having little

impact from the EMR intervention which ultimately
went live in March as well. Our pre-intervention
was a full year while our post-intervention was July
to March, and since the screening UACR is annual
we cannot see the full results of the intervention as
more screening could be scheduled later in the year.
Yet despite these factors, we still identiﬁed a signiﬁcant increase in diabetic nephropathy screening
which is promising.
Limitations include being a single-site and singleacademic year intervention. Increases in UACR
ordering could be partially from the Hawthorne
effect, as residents knew they were being monitored
and particularly 1/5th of the residents were leading
the project themselves, therefore very motivated. In
regard to resident knowledge assessment, the surveys had a high response rate, but residents were
not matched to answers in the pre and post questionnaires. Furthermore, low sample size due to size
of residency program and attendance at the didactic
session not being a requirement, made conclusions
from the survey limited. For future projects, tracking
responses by individual residents by establishing
unique identiﬁers and correctly identifying which
residents attended the didactic session would allow
us to increase power.
Future research. Future research can include
continued monitoring of diabetic nephropathy
screening to see if system-level changes were a

9

primary driver as these residents graduate and a
new set of residents begin. More research is needed
in the underinsured to identify effective approaches
for increasing screening compliance in this
population.
Conclusion. Through resident education, EMR
optimization and affordable lab order form updates,
our resident-led quality improvement project
increased screening for diabetic nephropathy from
20.7% to 32.7% thus reaching our aim of increasing
screening rate by 50%. We found the resident-led QI
project to be feasible and effective even in an underinsured and high-risk Hispanic population.

Disclaimers
Authors conﬁrm the article has not been submitted to other publications and/or presented at a
conference or meeting.

Source(s) of support
No grants, drug(s), equipment, and/or other support facilitated the conduct of the work.

Acknowledgements
We thank Sumandeep Brar, M.D. and Kalyana
Mondreti, M.D. for their contributions.

RESEARCH ARTICLE

JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES 2022;12:1e11

10

JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES 2022;12:1e11

RESEARCH ARTICLE

Appendix

Image 1. Pre-Intervention affordable lab order form.

Image 2. Post-Intervention affordable lab order form.
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